Rogel Cancer Center team gets $2M grant to train researchers in cancer care delivery

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

University of Michigan Rogel Cancer Center researchers received a $2 million grant from NCI to prepare the next generation of scientists focused on cancer care delivery.

This new training program focuses on preparing pre- and postdoctoral trainees from diverse disciplines to become independent investigators researching how cancer care is delivered and how to improve the care experience for patients with cancer.

“Recent advances in cancer therapies may be irrelevant if they cannot be given in a safe, effective, efficient, equitable and patient-centered manner across diverse treatment settings. We need more researchers to help discover care gaps, develop and test efficacious interventions, and implement discoveries into routine clinical practice,” principal investigator Christopher Friese, associate director for cancer control and population sciences at the Rogel Cancer Center and Elizabeth Tone Hosmer Professor of Nursing at the U-M School of Nursing, said in a statement.

The grant will fund a total of three predoctoral and fourteen postdoctoral students. With the support of their mentors, formal coursework, selected emphasis activities and professional socialization, trainees will acquire skills in descriptive discovery research, intervention development and testing, and implementation science to address gaps in the field.

The first predoctoral student and initial four postdoctoral students have been selected and will begin their training July 1.

Table of Contents

YOU MAY BE INTERESTED IN

At the Sept. 4 meeting of the National Cancer Advisory Board, NCI Principal Deputy Director Douglas R. Lowy provided an overview of how NCI is weathering the maelstrom of executive orders, policy changes, and funding uncertainties that has come down on federal agencies and research institutes since Donald Trump’s inauguration in January. 
A Senate hearing that the administration hoped would be a routine check-in on the president’s 2026 MAHA-driven healthcare agenda erupted into a political firestorm as senators jumped at their first opportunity to confront HHS Secretary Robert F. Kennedy Jr. over the chaos engulfing the Centers for Disease Control and Prevention.
In December 1971, President Richard Nixon signed the National Cancer Act and declared a “War on Cancer.” In the past 54 years, the U.S. has invested $180 billion nominally, or approximately $322 billion when adjusted for inflation, in cancer research. This investment has paid dividends with more than 100 anticancer drugs brought to market in half a century—virtually all traceable to National Cancer Institute funding. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login